SE7803363L - Forfarande for framstellning av oxazol- och tiazolalkansyraforeningar och salter derav - Google Patents

Forfarande for framstellning av oxazol- och tiazolalkansyraforeningar och salter derav

Info

Publication number
SE7803363L
SE7803363L SE7803363A SE7803363A SE7803363L SE 7803363 L SE7803363 L SE 7803363L SE 7803363 A SE7803363 A SE 7803363A SE 7803363 A SE7803363 A SE 7803363A SE 7803363 L SE7803363 L SE 7803363L
Authority
SE
Sweden
Prior art keywords
acanic
oxazole
thiazole
salts
procedure
Prior art date
Application number
SE7803363A
Other languages
English (en)
Inventor
T Yamanaka
H Yasuda
K Osuga
Original Assignee
Yoshitomi Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical filed Critical Yoshitomi Pharmaceutical
Publication of SE7803363L publication Critical patent/SE7803363L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/46—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/42—One oxygen atom attached in position 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7803363A 1977-03-25 1978-03-22 Forfarande for framstellning av oxazol- och tiazolalkansyraforeningar och salter derav SE7803363L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3346977A JPS53119866A (en) 1977-03-25 1977-03-25 5-aryloxy-oxazoleakanoic acid derivatives and their preparation

Publications (1)

Publication Number Publication Date
SE7803363L true SE7803363L (sv) 1978-09-26

Family

ID=12387395

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7803363A SE7803363L (sv) 1977-03-25 1978-03-22 Forfarande for framstellning av oxazol- och tiazolalkansyraforeningar och salter derav

Country Status (7)

Country Link
US (1) US4175130A (sv)
JP (1) JPS53119866A (sv)
BE (1) BE865332A (sv)
DE (1) DE2812353A1 (sv)
FR (1) FR2388804A1 (sv)
GB (1) GB1575190A (sv)
SE (1) SE7803363L (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5677268A (en) * 1979-11-28 1981-06-25 Yoshitomi Pharmaceut Ind Ltd Oxazoleacetic acid derivative
ATE144142T1 (de) * 1991-01-10 1996-11-15 Transcend Therapeutics Inc Verwendung von thiazolidin-4-carboxylatderivaten zur behandlung von lungenerkrankungen
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5866595A (en) * 1991-09-26 1999-02-02 The Regents Of The University Of California Calcium antagonists for treatment of vascular restenosis
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US5306724A (en) * 1992-08-17 1994-04-26 Clintec Nutrition Company Method for preventing and treating atherosclerosis
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
EP1419770A4 (en) * 2001-08-24 2005-08-03 Shionogi & Co AGENT ACC L RATION OF THE EXPRESSION OF APO AI
GB0323348D0 (en) * 2003-10-06 2003-11-05 Cambridge Theranostics Ltd Methods and means for modulating lipid metabolism

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2500142A (en) * 1947-04-24 1950-03-07 Gen Aniline & Film Corp Thio-ether substituted thiazoles and selenazoles and process of preparing the same
AR208400A1 (es) * 1974-03-13 1976-12-27 Yoshitomi Pharmaceutical Un metodo para producir nuevos acidos 5-alcoxi-4-oxazolalcanoicos 2-substituidos y sus esteres
US4053478A (en) * 1974-03-13 1977-10-11 Yoshitomi Pharmaceutical Industries, Ltd. 2,5-di-substituted 4-oxazolealkanoic acids and esters
JPS5217467A (en) 1975-07-25 1977-02-09 Yoshitomi Pharmaceut Ind Ltd Process for preparation of 5-alkoxy-2- oxazoleacetate or propionate de rivatives

Also Published As

Publication number Publication date
BE865332A (fr) 1978-09-25
GB1575190A (en) 1980-09-17
JPS53119866A (en) 1978-10-19
FR2388804A1 (fr) 1978-11-24
DE2812353A1 (de) 1978-09-28
US4175130A (en) 1979-11-20

Similar Documents

Publication Publication Date Title
NO802498L (no) Fremgangsmaate for fremstilling av clavulansyresalter
NO790358L (no) Fremgangsmaate for fremstilling av alkylendiaminderivater
NO801415L (no) Fremgangsmaate for fremstilling av antibakterielt aktive bisestere av metandiol med penicillinderivater
NO784397L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater
SE7801428L (sv) Forfarande for framstellning av cefemkarbonsyror
NO771578L (no) Fremgangsmaate for fremstilling av di-n-propyleddiksyre
NO792404L (no) Fremgangsmaate for fremstilling av imidazolderivater
SE7801973L (sv) Forfarande for framstellning av d,1-5-metyltetrafolsyra och dess salter
DK533979A (da) Fremgangsmaade til fremstilling af thiazolylderivater
SE7803363L (sv) Forfarande for framstellning av oxazol- och tiazolalkansyraforeningar och salter derav
NO791139L (no) Fremgangsmaate for fremstilling av lysergolderivater
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
NO780785L (no) Fremgangsmaate for fremstilling av optisk aktive 2-arylpropionsyrer
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
SE438337B (sv) Forfarande for framstellning av 2-(metyl)-7-substituerade 3-cefem-4-karboxylsyraforeningar
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater
SE7609719L (sv) Forfarande for framstellning av kvaternera salter
NO831258L (no) Fremstilling av 2-(3-arul-isoxazol-5-yl)-benzoyl-halogenider
NO149875C (no) Fremgangsmaate for fremstilling av insulin
NO800564L (no) Fremgangsmaate for fremstilling av penicillinderivater
NO802816L (no) Fremgangsmaate til fremstilling av n-r-d-glukaminsalter av d 2-(6-metoksy-2-naftyl)propionsyre
SE442748B (sv) Forfarande for framstellning av etrar av klavulansyra
AR220205A1 (es) Procedimiento de preparacion de nuevos derivados de n-(2-mercaptoetil-carbamoil)-alquil)-fenoxi-alcanoilamidas
NO150481C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater
SE7714971L (sv) Forfarande for framstellning av halogensulfonyltiofenkarbonsyraforeningar